Genome Editing: US FDA Eyes Platform-Based Approach To Development And Approval

 
• By Sue Sutter
Diving platform
Genome editing poses special considerations for the platform approach to development and regulatory review. • Source: Shutterstock

More from Cell & Gene Therapies

More from Advanced Technologies